Literature DB >> 12364339

Parkin accumulation in aggresomes due to proteasome impairment.

Eunsung Junn1, Sang Seop Lee, Unsun T Suhr, M Maral Mouradian.   

Abstract

Parkinson's disease (PD) is characterized by loss of dopaminergic neurons in the substantia nigra and by the presence of ubiquitinated cytoplasmic inclusions known as Lewy bodies. Alpha-synuclein and Parkin are two of the proteins associated with inherited forms of PD and are found in Lewy bodies. Whereas numerous reports indicate the tendency of alpha-synuclein to aggregate both in vitro and in vivo, no information is available about similar physical properties for Parkin. Here we show that overexpression of Parkin in the presence of proteasome inhibitors leads to the formation of aggresome-like perinuclear inclusions. These eosinophilic inclusions share many characteristics with Lewy bodies, including a core and halo organization, immunoreactivity to ubiquitin, alpha-synuclein, synphilin-1, Parkin, molecular chaperones, and proteasome subunit as well as staining of some with thioflavin S. We propose that the process of Lewy body formation may be akin to that of aggresome-like structures. The tendency of wild-type Parkin to aggregate and form inclusions may have implications for the pathogenesis of sporadic PD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12364339     DOI: 10.1074/jbc.M203159200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

Review 1.  Protein quality control during erythropoiesis and hemoglobin synthesis.

Authors:  Eugene Khandros; Mitchell J Weiss
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

2.  Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers.

Authors:  Pietro Fratta; W King Engel; Janis McFerrin; Kelvin J A Davies; Sharon W Lin; Valerie Askanas
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

Review 3.  Aggresome formation and neurodegenerative diseases: therapeutic implications.

Authors:  J A Olzmann; L Li; L S Chin
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

4.  The ubiquitin ligase E6-AP is induced and recruited to aggresomes in response to proteasome inhibition and may be involved in the ubiquitination of Hsp70-bound misfolded proteins.

Authors:  Amit Mishra; Swetha K Godavarthi; Megha Maheshwari; Anand Goswami; Nihar Ranjan Jana
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

Review 5.  Neurodegeneration and neuroprotection in Parkinson disease.

Authors:  Stanley Fahn; David Sulzer
Journal:  NeuroRx       Date:  2004-01

Review 6.  Misfolded proteins recognition strategies of E3 ubiquitin ligases and neurodegenerative diseases.

Authors:  Deepak Chhangani; Nihar Ranjan Jana; Amit Mishra
Journal:  Mol Neurobiol       Date:  2012-09-22       Impact factor: 5.590

7.  Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies.

Authors:  Eunsung Junn; Ruben D Ronchetti; Martha M Quezado; Soo-Youl Kim; M Maral Mouradian
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-07       Impact factor: 11.205

8.  Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin.

Authors:  Helen C Ardley; Gina B Scott; Stephen A Rose; Nancy G S Tan; Alexander F Markham; Philip A Robinson
Journal:  Mol Biol Cell       Date:  2003-08-22       Impact factor: 4.138

9.  Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43.

Authors:  Yoshinori Nishimoto; Daisuke Ito; Takuya Yagi; Yoshihiro Nihei; Yoshiko Tsunoda; Norihiro Suzuki
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

10.  Proteasome regulates turnover of toxic human amylin in pancreatic cells.

Authors:  Sanghamitra Singh; Saurabh Trikha; Anjali Sarkar; Aleksandar M Jeremic
Journal:  Biochem J       Date:  2016-06-23       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.